nodes	percent_of_prediction	percent_of_DWPC	metapath
Degarelix—Renal failure—Galantamine—Alzheimer's disease	0.00425	0.00441	CcSEcCtD
Degarelix—Hot flush—Memantine—Alzheimer's disease	0.00422	0.00438	CcSEcCtD
Degarelix—Urinary tract infection—Galantamine—Alzheimer's disease	0.0042	0.00436	CcSEcCtD
Degarelix—Menopausal symptoms—Memantine—Alzheimer's disease	0.00418	0.00434	CcSEcCtD
Degarelix—Atrial fibrillation—Memantine—Alzheimer's disease	0.00416	0.00432	CcSEcCtD
Degarelix—Libido decreased—Rivastigmine—Alzheimer's disease	0.00416	0.00432	CcSEcCtD
Degarelix—Renal impairment—Memantine—Alzheimer's disease	0.00415	0.00431	CcSEcCtD
Degarelix—Hot flush—Rivastigmine—Alzheimer's disease	0.00413	0.00429	CcSEcCtD
Degarelix—Menopausal symptoms—Rivastigmine—Alzheimer's disease	0.00409	0.00425	CcSEcCtD
Degarelix—Hepatobiliary disease—Galantamine—Alzheimer's disease	0.00409	0.00424	CcSEcCtD
Degarelix—Atrial fibrillation—Rivastigmine—Alzheimer's disease	0.00407	0.00423	CcSEcCtD
Degarelix—Renal impairment—Rivastigmine—Alzheimer's disease	0.00406	0.00421	CcSEcCtD
Degarelix—Cardiac failure—Memantine—Alzheimer's disease	0.00404	0.0042	CcSEcCtD
Degarelix—Cardiac failure—Rivastigmine—Alzheimer's disease	0.00396	0.00411	CcSEcCtD
Degarelix—Disturbance in sexual arousal—Memantine—Alzheimer's disease	0.00392	0.00407	CcSEcCtD
Degarelix—Muscular weakness—Donepezil—Alzheimer's disease	0.00383	0.00398	CcSEcCtD
Degarelix—Urinary tract disorder—Galantamine—Alzheimer's disease	0.00383	0.00398	CcSEcCtD
Degarelix—Disturbance in sexual arousal—Rivastigmine—Alzheimer's disease	0.00383	0.00398	CcSEcCtD
Degarelix—Oedema peripheral—Galantamine—Alzheimer's disease	0.00382	0.00397	CcSEcCtD
Degarelix—Urethral disorder—Galantamine—Alzheimer's disease	0.0038	0.00395	CcSEcCtD
Degarelix—Eye disorder—Galantamine—Alzheimer's disease	0.00363	0.00377	CcSEcCtD
Degarelix—Abdominal discomfort—Donepezil—Alzheimer's disease	0.0036	0.00374	CcSEcCtD
Degarelix—Cardiac disorder—Galantamine—Alzheimer's disease	0.0036	0.00374	CcSEcCtD
Degarelix—Angiopathy—Galantamine—Alzheimer's disease	0.00352	0.00366	CcSEcCtD
Degarelix—Dysuria—Donepezil—Alzheimer's disease	0.00351	0.00365	CcSEcCtD
Degarelix—Immune system disorder—Galantamine—Alzheimer's disease	0.0035	0.00364	CcSEcCtD
Degarelix—Breast disorder—Rivastigmine—Alzheimer's disease	0.00349	0.00362	CcSEcCtD
Degarelix—Muscular weakness—Memantine—Alzheimer's disease	0.00348	0.00361	CcSEcCtD
Degarelix—Pollakiuria—Donepezil—Alzheimer's disease	0.00347	0.0036	CcSEcCtD
Degarelix—Arrhythmia—Galantamine—Alzheimer's disease	0.00347	0.0036	CcSEcCtD
Degarelix—Weight increased—Donepezil—Alzheimer's disease	0.00342	0.00355	CcSEcCtD
Degarelix—Muscular weakness—Rivastigmine—Alzheimer's disease	0.00341	0.00354	CcSEcCtD
Degarelix—Mental disorder—Galantamine—Alzheimer's disease	0.0034	0.00353	CcSEcCtD
Degarelix—Weight decreased—Donepezil—Alzheimer's disease	0.0034	0.00353	CcSEcCtD
Degarelix—Hyperglycaemia—Donepezil—Alzheimer's disease	0.00339	0.00352	CcSEcCtD
Degarelix—Malnutrition—Galantamine—Alzheimer's disease	0.00338	0.00351	CcSEcCtD
Degarelix—Depression—Donepezil—Alzheimer's disease	0.00334	0.00347	CcSEcCtD
Degarelix—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.0033	0.00343	CcSEcCtD
Degarelix—Renal failure—Donepezil—Alzheimer's disease	0.00329	0.00342	CcSEcCtD
Degarelix—Myocardial infarction—Donepezil—Alzheimer's disease	0.00328	0.00341	CcSEcCtD
Degarelix—Back pain—Galantamine—Alzheimer's disease	0.00327	0.00339	CcSEcCtD
Degarelix—Urinary tract infection—Donepezil—Alzheimer's disease	0.00326	0.00338	CcSEcCtD
Degarelix—Muscle spasms—Galantamine—Alzheimer's disease	0.00325	0.00337	CcSEcCtD
Degarelix—Dysuria—Memantine—Alzheimer's disease	0.00319	0.00331	CcSEcCtD
Degarelix—Vision blurred—Galantamine—Alzheimer's disease	0.00318	0.00331	CcSEcCtD
Degarelix—Pollakiuria—Memantine—Alzheimer's disease	0.00315	0.00327	CcSEcCtD
Degarelix—Erectile dysfunction—Memantine—Alzheimer's disease	0.00314	0.00326	CcSEcCtD
Degarelix—Ill-defined disorder—Galantamine—Alzheimer's disease	0.00313	0.00325	CcSEcCtD
Degarelix—Anaemia—Galantamine—Alzheimer's disease	0.00312	0.00324	CcSEcCtD
Degarelix—Dysuria—Rivastigmine—Alzheimer's disease	0.00312	0.00324	CcSEcCtD
Degarelix—Weight increased—Memantine—Alzheimer's disease	0.0031	0.00322	CcSEcCtD
Degarelix—Weight decreased—Memantine—Alzheimer's disease	0.00309	0.0032	CcSEcCtD
Degarelix—Pollakiuria—Rivastigmine—Alzheimer's disease	0.00308	0.0032	CcSEcCtD
Degarelix—Hyperglycaemia—Memantine—Alzheimer's disease	0.00308	0.00319	CcSEcCtD
Degarelix—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.00307	0.00319	CcSEcCtD
Degarelix—Malaise—Galantamine—Alzheimer's disease	0.00305	0.00316	CcSEcCtD
Degarelix—Weight increased—Rivastigmine—Alzheimer's disease	0.00304	0.00315	CcSEcCtD
Degarelix—Depression—Memantine—Alzheimer's disease	0.00303	0.00315	CcSEcCtD
Degarelix—Weight decreased—Rivastigmine—Alzheimer's disease	0.00302	0.00313	CcSEcCtD
Degarelix—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.00301	0.00313	CcSEcCtD
Degarelix—Acute coronary syndrome—Memantine—Alzheimer's disease	0.003	0.00311	CcSEcCtD
Degarelix—Hypoaesthesia—Donepezil—Alzheimer's disease	0.00299	0.00311	CcSEcCtD
Degarelix—Renal failure—Memantine—Alzheimer's disease	0.00299	0.0031	CcSEcCtD
Degarelix—Palpitations—Galantamine—Alzheimer's disease	0.00298	0.0031	CcSEcCtD
Degarelix—Myocardial infarction—Memantine—Alzheimer's disease	0.00298	0.0031	CcSEcCtD
Degarelix—Urinary tract disorder—Donepezil—Alzheimer's disease	0.00297	0.00308	CcSEcCtD
Degarelix—Depression—Rivastigmine—Alzheimer's disease	0.00297	0.00308	CcSEcCtD
Degarelix—Oedema peripheral—Donepezil—Alzheimer's disease	0.00296	0.00308	CcSEcCtD
Degarelix—Urinary tract infection—Memantine—Alzheimer's disease	0.00296	0.00307	CcSEcCtD
Degarelix—Urethral disorder—Donepezil—Alzheimer's disease	0.00295	0.00306	CcSEcCtD
Degarelix—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.00293	0.00305	CcSEcCtD
Degarelix—Renal failure—Rivastigmine—Alzheimer's disease	0.00292	0.00304	CcSEcCtD
Degarelix—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.00292	0.00303	CcSEcCtD
Degarelix—Hypertension—Galantamine—Alzheimer's disease	0.00292	0.00303	CcSEcCtD
Degarelix—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.00289	0.003	CcSEcCtD
Degarelix—Hepatobiliary disease—Memantine—Alzheimer's disease	0.00288	0.00299	CcSEcCtD
Degarelix—Arthralgia—Galantamine—Alzheimer's disease	0.00288	0.00299	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00286	0.00297	CcSEcCtD
Degarelix—Discomfort—Galantamine—Alzheimer's disease	0.00284	0.00295	CcSEcCtD
Degarelix—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.00281	0.00292	CcSEcCtD
Degarelix—Dry mouth—Galantamine—Alzheimer's disease	0.00281	0.00292	CcSEcCtD
Degarelix—Hypoaesthesia—Memantine—Alzheimer's disease	0.00272	0.00282	CcSEcCtD
Degarelix—Nervous system disorder—Galantamine—Alzheimer's disease	0.0027	0.00281	CcSEcCtD
Degarelix—Chills—Donepezil—Alzheimer's disease	0.0027	0.0028	CcSEcCtD
Degarelix—Urinary tract disorder—Memantine—Alzheimer's disease	0.0027	0.0028	CcSEcCtD
Degarelix—Oedema peripheral—Memantine—Alzheimer's disease	0.00269	0.00279	CcSEcCtD
Degarelix—Arrhythmia—Donepezil—Alzheimer's disease	0.00269	0.00279	CcSEcCtD
Degarelix—Skin disorder—Galantamine—Alzheimer's disease	0.00268	0.00278	CcSEcCtD
Degarelix—Urethral disorder—Memantine—Alzheimer's disease	0.00268	0.00278	CcSEcCtD
Degarelix—Hyperhidrosis—Galantamine—Alzheimer's disease	0.00266	0.00277	CcSEcCtD
Degarelix—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.00266	0.00276	CcSEcCtD
Degarelix—Alopecia—Donepezil—Alzheimer's disease	0.00266	0.00276	CcSEcCtD
Degarelix—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.00264	0.00274	CcSEcCtD
Degarelix—Mental disorder—Donepezil—Alzheimer's disease	0.00263	0.00274	CcSEcCtD
Degarelix—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.00263	0.00273	CcSEcCtD
Degarelix—Urethral disorder—Rivastigmine—Alzheimer's disease	0.00262	0.00272	CcSEcCtD
Degarelix—Erythema—Donepezil—Alzheimer's disease	0.00262	0.00272	CcSEcCtD
Degarelix—Malnutrition—Donepezil—Alzheimer's disease	0.00262	0.00272	CcSEcCtD
Degarelix—Hypotension—Galantamine—Alzheimer's disease	0.00258	0.00267	CcSEcCtD
Degarelix—Eye disorder—Memantine—Alzheimer's disease	0.00255	0.00265	CcSEcCtD
Degarelix—Cardiac disorder—Memantine—Alzheimer's disease	0.00253	0.00263	CcSEcCtD
Degarelix—Back pain—Donepezil—Alzheimer's disease	0.00253	0.00263	CcSEcCtD
Degarelix—Muscle spasms—Donepezil—Alzheimer's disease	0.00252	0.00261	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.00251	0.00261	CcSEcCtD
Degarelix—Eye disorder—Rivastigmine—Alzheimer's disease	0.0025	0.00259	CcSEcCtD
Degarelix—Insomnia—Galantamine—Alzheimer's disease	0.00249	0.00259	CcSEcCtD
Degarelix—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.00248	0.00257	CcSEcCtD
Degarelix—Angiopathy—Memantine—Alzheimer's disease	0.00248	0.00257	CcSEcCtD
Degarelix—Vision blurred—Donepezil—Alzheimer's disease	0.00247	0.00256	CcSEcCtD
Degarelix—Immune system disorder—Memantine—Alzheimer's disease	0.00247	0.00256	CcSEcCtD
Degarelix—Mediastinal disorder—Memantine—Alzheimer's disease	0.00246	0.00255	CcSEcCtD
Degarelix—Chills—Memantine—Alzheimer's disease	0.00245	0.00254	CcSEcCtD
Degarelix—Arrhythmia—Memantine—Alzheimer's disease	0.00244	0.00253	CcSEcCtD
Degarelix—Ill-defined disorder—Donepezil—Alzheimer's disease	0.00243	0.00252	CcSEcCtD
Degarelix—Angiopathy—Rivastigmine—Alzheimer's disease	0.00242	0.00252	CcSEcCtD
Degarelix—Anaemia—Donepezil—Alzheimer's disease	0.00242	0.00251	CcSEcCtD
Degarelix—Alopecia—Memantine—Alzheimer's disease	0.00241	0.00251	CcSEcCtD
Degarelix—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.00241	0.0025	CcSEcCtD
Degarelix—Chills—Rivastigmine—Alzheimer's disease	0.0024	0.00249	CcSEcCtD
Degarelix—Decreased appetite—Galantamine—Alzheimer's disease	0.0024	0.00249	CcSEcCtD
Degarelix—Mental disorder—Memantine—Alzheimer's disease	0.00239	0.00248	CcSEcCtD
Degarelix—Arrhythmia—Rivastigmine—Alzheimer's disease	0.00239	0.00248	CcSEcCtD
Degarelix—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00238	0.00247	CcSEcCtD
Degarelix—Malnutrition—Memantine—Alzheimer's disease	0.00238	0.00247	CcSEcCtD
Degarelix—Fatigue—Galantamine—Alzheimer's disease	0.00238	0.00247	CcSEcCtD
Degarelix—Malaise—Donepezil—Alzheimer's disease	0.00236	0.00245	CcSEcCtD
Degarelix—Alopecia—Rivastigmine—Alzheimer's disease	0.00236	0.00245	CcSEcCtD
Degarelix—Constipation—Galantamine—Alzheimer's disease	0.00236	0.00245	CcSEcCtD
Degarelix—Mental disorder—Rivastigmine—Alzheimer's disease	0.00234	0.00243	CcSEcCtD
Degarelix—Erythema—Rivastigmine—Alzheimer's disease	0.00232	0.00241	CcSEcCtD
Degarelix—Malnutrition—Rivastigmine—Alzheimer's disease	0.00232	0.00241	CcSEcCtD
Degarelix—Back pain—Memantine—Alzheimer's disease	0.0023	0.00239	CcSEcCtD
Degarelix—Feeling abnormal—Galantamine—Alzheimer's disease	0.00227	0.00236	CcSEcCtD
Degarelix—Hypertension—Donepezil—Alzheimer's disease	0.00226	0.00235	CcSEcCtD
Degarelix—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00225	0.00234	CcSEcCtD
Degarelix—Back pain—Rivastigmine—Alzheimer's disease	0.00225	0.00234	CcSEcCtD
Degarelix—Vision blurred—Memantine—Alzheimer's disease	0.00224	0.00233	CcSEcCtD
Degarelix—Muscle spasms—Rivastigmine—Alzheimer's disease	0.00224	0.00232	CcSEcCtD
Degarelix—Arthralgia—Donepezil—Alzheimer's disease	0.00223	0.00231	CcSEcCtD
Degarelix—Ill-defined disorder—Memantine—Alzheimer's disease	0.00221	0.00229	CcSEcCtD
Degarelix—Discomfort—Donepezil—Alzheimer's disease	0.0022	0.00229	CcSEcCtD
Degarelix—Anaemia—Memantine—Alzheimer's disease	0.0022	0.00228	CcSEcCtD
Degarelix—Vision blurred—Rivastigmine—Alzheimer's disease	0.00219	0.00228	CcSEcCtD
Degarelix—Dry mouth—Donepezil—Alzheimer's disease	0.00218	0.00226	CcSEcCtD
Degarelix—Abdominal pain—Galantamine—Alzheimer's disease	0.00218	0.00226	CcSEcCtD
Degarelix—Body temperature increased—Galantamine—Alzheimer's disease	0.00218	0.00226	CcSEcCtD
Degarelix—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.00216	0.00224	CcSEcCtD
Degarelix—Anaemia—Rivastigmine—Alzheimer's disease	0.00215	0.00223	CcSEcCtD
Degarelix—Malaise—Memantine—Alzheimer's disease	0.00214	0.00223	CcSEcCtD
Degarelix—Palpitations—Memantine—Alzheimer's disease	0.0021	0.00218	CcSEcCtD
Degarelix—Malaise—Rivastigmine—Alzheimer's disease	0.0021	0.00218	CcSEcCtD
Degarelix—Nervous system disorder—Donepezil—Alzheimer's disease	0.00209	0.00218	CcSEcCtD
Degarelix—Hyperhidrosis—Donepezil—Alzheimer's disease	0.00207	0.00214	CcSEcCtD
Degarelix—Palpitations—Rivastigmine—Alzheimer's disease	0.00205	0.00213	CcSEcCtD
Degarelix—Hypertension—Memantine—Alzheimer's disease	0.00205	0.00213	CcSEcCtD
Degarelix—Hypersensitivity—Galantamine—Alzheimer's disease	0.00203	0.00211	CcSEcCtD
Degarelix—Arthralgia—Memantine—Alzheimer's disease	0.00202	0.0021	CcSEcCtD
Degarelix—Hypertension—Rivastigmine—Alzheimer's disease	0.00201	0.00208	CcSEcCtD
Degarelix—Discomfort—Memantine—Alzheimer's disease	0.002	0.00208	CcSEcCtD
Degarelix—Hypotension—Donepezil—Alzheimer's disease	0.002	0.00207	CcSEcCtD
Degarelix—Arthralgia—Rivastigmine—Alzheimer's disease	0.00198	0.00206	CcSEcCtD
Degarelix—Dry mouth—Memantine—Alzheimer's disease	0.00198	0.00205	CcSEcCtD
Degarelix—Asthenia—Galantamine—Alzheimer's disease	0.00198	0.00205	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.00197	0.00204	CcSEcCtD
Degarelix—Discomfort—Rivastigmine—Alzheimer's disease	0.00196	0.00203	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.00195	0.00202	CcSEcCtD
Degarelix—Dry mouth—Rivastigmine—Alzheimer's disease	0.00194	0.00201	CcSEcCtD
Degarelix—Insomnia—Donepezil—Alzheimer's disease	0.00193	0.00201	CcSEcCtD
Degarelix—Dyspnoea—Donepezil—Alzheimer's disease	0.0019	0.00198	CcSEcCtD
Degarelix—Nervous system disorder—Memantine—Alzheimer's disease	0.0019	0.00198	CcSEcCtD
Degarelix—Diarrhoea—Galantamine—Alzheimer's disease	0.00189	0.00196	CcSEcCtD
Degarelix—Skin disorder—Memantine—Alzheimer's disease	0.00188	0.00196	CcSEcCtD
Degarelix—Hyperhidrosis—Memantine—Alzheimer's disease	0.00188	0.00195	CcSEcCtD
Degarelix—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.00186	0.00193	CcSEcCtD
Degarelix—Decreased appetite—Donepezil—Alzheimer's disease	0.00186	0.00193	CcSEcCtD
Degarelix—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.00184	0.00192	CcSEcCtD
Degarelix—Skin disorder—Rivastigmine—Alzheimer's disease	0.00184	0.00191	CcSEcCtD
Degarelix—Fatigue—Donepezil—Alzheimer's disease	0.00184	0.00191	CcSEcCtD
Degarelix—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.00183	0.0019	CcSEcCtD
Degarelix—Pain—Donepezil—Alzheimer's disease	0.00183	0.0019	CcSEcCtD
Degarelix—Constipation—Donepezil—Alzheimer's disease	0.00183	0.0019	CcSEcCtD
Degarelix—Dizziness—Galantamine—Alzheimer's disease	0.00182	0.00189	CcSEcCtD
Degarelix—Hypotension—Memantine—Alzheimer's disease	0.00181	0.00188	CcSEcCtD
Degarelix—Hypotension—Rivastigmine—Alzheimer's disease	0.00177	0.00184	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.00177	0.00184	CcSEcCtD
Degarelix—Feeling abnormal—Donepezil—Alzheimer's disease	0.00176	0.00183	CcSEcCtD
Degarelix—Insomnia—Memantine—Alzheimer's disease	0.00175	0.00182	CcSEcCtD
Degarelix—Vomiting—Galantamine—Alzheimer's disease	0.00175	0.00182	CcSEcCtD
Degarelix—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.00175	0.00181	CcSEcCtD
Degarelix—Rash—Galantamine—Alzheimer's disease	0.00174	0.0018	CcSEcCtD
Degarelix—Dermatitis—Galantamine—Alzheimer's disease	0.00174	0.0018	CcSEcCtD
Degarelix—Dyspnoea—Memantine—Alzheimer's disease	0.00173	0.0018	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.00173	0.0018	CcSEcCtD
Degarelix—Headache—Galantamine—Alzheimer's disease	0.00173	0.00179	CcSEcCtD
Degarelix—Insomnia—Rivastigmine—Alzheimer's disease	0.00172	0.00178	CcSEcCtD
Degarelix—Urticaria—Donepezil—Alzheimer's disease	0.0017	0.00176	CcSEcCtD
Degarelix—Dyspnoea—Rivastigmine—Alzheimer's disease	0.00169	0.00176	CcSEcCtD
Degarelix—Abdominal pain—Donepezil—Alzheimer's disease	0.00169	0.00175	CcSEcCtD
Degarelix—Body temperature increased—Donepezil—Alzheimer's disease	0.00169	0.00175	CcSEcCtD
Degarelix—Decreased appetite—Memantine—Alzheimer's disease	0.00169	0.00175	CcSEcCtD
Degarelix—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.00167	0.00174	CcSEcCtD
Degarelix—Fatigue—Memantine—Alzheimer's disease	0.00167	0.00174	CcSEcCtD
Degarelix—Constipation—Memantine—Alzheimer's disease	0.00166	0.00172	CcSEcCtD
Degarelix—Pain—Memantine—Alzheimer's disease	0.00166	0.00172	CcSEcCtD
Degarelix—Decreased appetite—Rivastigmine—Alzheimer's disease	0.00165	0.00171	CcSEcCtD
Degarelix—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00164	0.0017	CcSEcCtD
Degarelix—Nausea—Galantamine—Alzheimer's disease	0.00164	0.0017	CcSEcCtD
Degarelix—Fatigue—Rivastigmine—Alzheimer's disease	0.00164	0.0017	CcSEcCtD
Degarelix—Pain—Rivastigmine—Alzheimer's disease	0.00162	0.00168	CcSEcCtD
Degarelix—Constipation—Rivastigmine—Alzheimer's disease	0.00162	0.00168	CcSEcCtD
Degarelix—Feeling abnormal—Memantine—Alzheimer's disease	0.0016	0.00166	CcSEcCtD
Degarelix—Gastrointestinal pain—Memantine—Alzheimer's disease	0.00159	0.00165	CcSEcCtD
Degarelix—Hypersensitivity—Donepezil—Alzheimer's disease	0.00157	0.00163	CcSEcCtD
Degarelix—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.00156	0.00162	CcSEcCtD
Degarelix—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.00155	0.00161	CcSEcCtD
Degarelix—Urticaria—Memantine—Alzheimer's disease	0.00154	0.0016	CcSEcCtD
Degarelix—Abdominal pain—Memantine—Alzheimer's disease	0.00153	0.00159	CcSEcCtD
Degarelix—Body temperature increased—Memantine—Alzheimer's disease	0.00153	0.00159	CcSEcCtD
Degarelix—Asthenia—Donepezil—Alzheimer's disease	0.00153	0.00159	CcSEcCtD
Degarelix—Pruritus—Donepezil—Alzheimer's disease	0.00151	0.00157	CcSEcCtD
Degarelix—Urticaria—Rivastigmine—Alzheimer's disease	0.00151	0.00157	CcSEcCtD
Degarelix—Body temperature increased—Rivastigmine—Alzheimer's disease	0.0015	0.00156	CcSEcCtD
Degarelix—Abdominal pain—Rivastigmine—Alzheimer's disease	0.0015	0.00156	CcSEcCtD
Degarelix—Diarrhoea—Donepezil—Alzheimer's disease	0.00146	0.00152	CcSEcCtD
Degarelix—Hypersensitivity—Memantine—Alzheimer's disease	0.00143	0.00148	CcSEcCtD
Degarelix—Dizziness—Donepezil—Alzheimer's disease	0.00141	0.00147	CcSEcCtD
Degarelix—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.0014	0.00145	CcSEcCtD
Degarelix—Asthenia—Memantine—Alzheimer's disease	0.00139	0.00145	CcSEcCtD
Degarelix—Pruritus—Memantine—Alzheimer's disease	0.00137	0.00142	CcSEcCtD
Degarelix—Asthenia—Rivastigmine—Alzheimer's disease	0.00136	0.00141	CcSEcCtD
Degarelix—Vomiting—Donepezil—Alzheimer's disease	0.00136	0.00141	CcSEcCtD
Degarelix—Rash—Donepezil—Alzheimer's disease	0.00135	0.0014	CcSEcCtD
Degarelix—Dermatitis—Donepezil—Alzheimer's disease	0.00135	0.0014	CcSEcCtD
Degarelix—Pruritus—Rivastigmine—Alzheimer's disease	0.00134	0.00139	CcSEcCtD
Degarelix—Headache—Donepezil—Alzheimer's disease	0.00134	0.00139	CcSEcCtD
Degarelix—Diarrhoea—Memantine—Alzheimer's disease	0.00133	0.00138	CcSEcCtD
Degarelix—Diarrhoea—Rivastigmine—Alzheimer's disease	0.0013	0.00135	CcSEcCtD
Degarelix—Dizziness—Memantine—Alzheimer's disease	0.00128	0.00133	CcSEcCtD
Degarelix—Nausea—Donepezil—Alzheimer's disease	0.00127	0.00132	CcSEcCtD
Degarelix—Dizziness—Rivastigmine—Alzheimer's disease	0.00125	0.0013	CcSEcCtD
Degarelix—Vomiting—Memantine—Alzheimer's disease	0.00123	0.00128	CcSEcCtD
Degarelix—Rash—Memantine—Alzheimer's disease	0.00122	0.00127	CcSEcCtD
Degarelix—Dermatitis—Memantine—Alzheimer's disease	0.00122	0.00127	CcSEcCtD
Degarelix—Headache—Memantine—Alzheimer's disease	0.00122	0.00126	CcSEcCtD
Degarelix—Vomiting—Rivastigmine—Alzheimer's disease	0.00121	0.00125	CcSEcCtD
Degarelix—Rash—Rivastigmine—Alzheimer's disease	0.0012	0.00124	CcSEcCtD
Degarelix—Dermatitis—Rivastigmine—Alzheimer's disease	0.0012	0.00124	CcSEcCtD
Degarelix—Headache—Rivastigmine—Alzheimer's disease	0.00119	0.00123	CcSEcCtD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—PYY—Alzheimer's disease	0.00116	0.0313	CbGpPWpGaD
Degarelix—Nausea—Memantine—Alzheimer's disease	0.00115	0.0012	CcSEcCtD
Degarelix—Nausea—Rivastigmine—Alzheimer's disease	0.00113	0.00117	CcSEcCtD
Degarelix—GNRHR—Peptide GPCRs—CCR5—Alzheimer's disease	0.00112	0.0303	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—HTR6—Alzheimer's disease	0.000965	0.0261	CbGpPWpGaD
Degarelix—GNRHR—GPCRs, Other—CCR5—Alzheimer's disease	0.000951	0.0257	CbGpPWpGaD
Degarelix—GNRHR—GPCRs, Other—HTR2A—Alzheimer's disease	0.00093	0.0252	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—PYY—Alzheimer's disease	0.00088	0.0238	CbGpPWpGaD
Degarelix—GNRHR—G alpha (q) signalling events—NPS—Alzheimer's disease	0.000869	0.0235	CbGpPWpGaD
Degarelix—GNRHR—G alpha (q) signalling events—APP—Alzheimer's disease	0.000808	0.0219	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—GAL—Alzheimer's disease	0.000801	0.0217	CbGpPWpGaD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—Alzheimer's disease	0.000777	0.021	CbGpPWpGaD
Degarelix—GNRHR—G alpha (q) signalling events—PLCB1—Alzheimer's disease	0.000763	0.0206	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—HTR6—Alzheimer's disease	0.000735	0.0199	CbGpPWpGaD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—APP—Alzheimer's disease	0.000723	0.0195	CbGpPWpGaD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—PLCB1—Alzheimer's disease	0.000682	0.0184	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—NPY—Alzheimer's disease	0.000629	0.017	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—GAL—Alzheimer's disease	0.00061	0.0165	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—NPS—Alzheimer's disease	0.000576	0.0156	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—SST—Alzheimer's disease	0.000549	0.0149	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—APP—Alzheimer's disease	0.000535	0.0145	CbGpPWpGaD
Degarelix—GNRHR—G alpha (q) signalling events—HTR2A—Alzheimer's disease	0.000523	0.0141	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—PYY—Alzheimer's disease	0.000497	0.0135	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—NPY—Alzheimer's disease	0.000479	0.013	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—IAPP—Alzheimer's disease	0.000476	0.0129	CbGpPWpGaD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Alzheimer's disease	0.000468	0.0126	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—CRH—Alzheimer's disease	0.000462	0.0125	CbGpPWpGaD
Degarelix—GNRHR—G alpha (q) signalling events—F2—Alzheimer's disease	0.000458	0.0124	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—PYY—Alzheimer's disease	0.000452	0.0122	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—NPS—Alzheimer's disease	0.000438	0.0119	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—SST—Alzheimer's disease	0.000418	0.0113	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—HTR6—Alzheimer's disease	0.000415	0.0112	CbGpPWpGaD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—F2—Alzheimer's disease	0.00041	0.0111	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—APP—Alzheimer's disease	0.000408	0.011	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—CDK5—Alzheimer's disease	0.000392	0.0106	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—HTR6—Alzheimer's disease	0.000377	0.0102	CbGpPWpGaD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—CREB1—Alzheimer's disease	0.000374	0.0101	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	0.000354	0.00957	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	0.000346	0.00937	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—GAL—Alzheimer's disease	0.000345	0.00933	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—GAL—Alzheimer's disease	0.000313	0.00847	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—TTR—Alzheimer's disease	0.000305	0.00826	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	0.000304	0.00821	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—NPY—Alzheimer's disease	0.000271	0.00733	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	0.000271	0.00732	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—CCR5—Alzheimer's disease	0.000269	0.00729	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—IAPP—Alzheimer's disease	0.000269	0.00728	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—PYY—Alzheimer's disease	0.000267	0.00722	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—HTR2A—Alzheimer's disease	0.000264	0.00713	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—CRH—Alzheimer's disease	0.000261	0.00707	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—NPS—Alzheimer's disease	0.000248	0.0067	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—NPY—Alzheimer's disease	0.000246	0.00665	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—IAPP—Alzheimer's disease	0.000244	0.00661	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—CRH—Alzheimer's disease	0.000237	0.00642	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—SST—Alzheimer's disease	0.000236	0.00639	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—GAB2—Alzheimer's disease	0.000236	0.00639	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CDK5—Alzheimer's disease	0.000231	0.00626	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—F2—Alzheimer's disease	0.000231	0.00625	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—APP—Alzheimer's disease	0.00023	0.00623	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—NPS—Alzheimer's disease	0.000225	0.00608	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—PPP3CA—Alzheimer's disease	0.000224	0.00605	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—HTR6—Alzheimer's disease	0.000223	0.00602	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—PLCB1—Alzheimer's disease	0.000217	0.00588	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—GAB2—Alzheimer's disease	0.000215	0.0058	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—SST—Alzheimer's disease	0.000215	0.0058	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—APP—Alzheimer's disease	0.000209	0.00566	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—CCL2—Alzheimer's disease	0.000206	0.00557	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—PSENEN—Alzheimer's disease	0.000202	0.00547	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—APH1A—Alzheimer's disease	0.000199	0.00539	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—PLCB1—Alzheimer's disease	0.000197	0.00534	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—NCSTN—Alzheimer's disease	0.000194	0.00525	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—LRP1—Alzheimer's disease	0.000189	0.00512	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—GAL—Alzheimer's disease	0.000185	0.005	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—GFAP—Alzheimer's disease	0.000185	0.005	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—A2M—Alzheimer's disease	0.000163	0.00441	CbGpPWpGaD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	0.000162	0.00439	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.000161	0.00435	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—PSEN2—Alzheimer's disease	0.000158	0.00427	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—CCR5—Alzheimer's disease	0.000152	0.00412	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.000149	0.00403	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000146	0.00395	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—NPY—Alzheimer's disease	0.000145	0.00393	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—IAPP—Alzheimer's disease	0.000144	0.00391	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CRH—Alzheimer's disease	0.00014	0.00379	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—CCR5—Alzheimer's disease	0.000138	0.00374	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000135	0.00366	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—NPS—Alzheimer's disease	0.000133	0.00359	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—PPP3CA—Alzheimer's disease	0.000132	0.00358	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—F2—Alzheimer's disease	0.000131	0.00353	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—PTK2B—Alzheimer's disease	0.00013	0.00352	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—GAB2—Alzheimer's disease	0.000127	0.00343	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—SST—Alzheimer's disease	0.000127	0.00343	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—NTRK2—Alzheimer's disease	0.000127	0.00343	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—CALM1—Alzheimer's disease	0.000126	0.00341	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—GSK3A—Alzheimer's disease	0.000126	0.0034	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—APP—Alzheimer's disease	0.000124	0.00334	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—F2—Alzheimer's disease	0.000119	0.00321	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—PLCB1—Alzheimer's disease	0.000117	0.00315	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—NGFR—Alzheimer's disease	0.000109	0.00294	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—CREB1—Alzheimer's disease	0.000108	0.00292	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—ADAM10—Alzheimer's disease	0.000106	0.00287	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—CCL2—Alzheimer's disease	0.000106	0.00286	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—S100B—Alzheimer's disease	0.0001	0.00272	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—IGF2—Alzheimer's disease	9.57e-05	0.00259	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—IGF1R—Alzheimer's disease	9.25e-05	0.0025	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—LPL—Alzheimer's disease	8.87e-05	0.0024	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—MEF2C—Alzheimer's disease	8.79e-05	0.00238	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—PRKCG—Alzheimer's disease	8.62e-05	0.00233	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—NGF—Alzheimer's disease	8.4e-05	0.00227	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CCR5—Alzheimer's disease	8.17e-05	0.00221	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—HTR2A—Alzheimer's disease	7.99e-05	0.00216	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CALM1—Alzheimer's disease	7.46e-05	0.00202	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—LEP—Alzheimer's disease	7.43e-05	0.00201	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—APOE—Alzheimer's disease	7.43e-05	0.00201	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CAV1—Alzheimer's disease	7.36e-05	0.00199	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—ESR1—Alzheimer's disease	7.1e-05	0.00192	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—F2—Alzheimer's disease	7.01e-05	0.0019	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—NOTCH1—Alzheimer's disease	6.86e-05	0.00185	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—GSK3B—Alzheimer's disease	6.44e-05	0.00174	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CREB1—Alzheimer's disease	6.38e-05	0.00173	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—INS—Alzheimer's disease	6.35e-05	0.00172	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CCL2—Alzheimer's disease	6.25e-05	0.00169	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—IGF1—Alzheimer's disease	6.14e-05	0.00166	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—NOS3—Alzheimer's disease	5.57e-05	0.00151	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—AKT1—Alzheimer's disease	4.77e-05	0.00129	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CASP3—Alzheimer's disease	4.73e-05	0.00128	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—IL6—Alzheimer's disease	4.7e-05	0.00127	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—MAPK8—Alzheimer's disease	4.34e-05	0.00117	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—AKT1—Alzheimer's disease	4.33e-05	0.00117	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—VEGFA—Alzheimer's disease	4.01e-05	0.00108	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—TGFB1—Alzheimer's disease	3.68e-05	0.000996	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—TP53—Alzheimer's disease	3.03e-05	0.00082	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—IL6—Alzheimer's disease	2.77e-05	0.00075	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—AKT1—Alzheimer's disease	2.56e-05	0.000692	CbGpPWpGaD
